NYSEARCA:IDIV Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 (IDIV) Price, Holdings, & News $6.96 -0.10 (-1.42%) As of 12/9/2022 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 (NYSEARCA:IDIV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IDIV alerts:Sign Up Key Stats Today's Range$6.96▼$7.0550-Day Range$6.96▼$6.9652-Week Range$6.70▼$10.76Volume10,200 shsAverage Volume27,145 shsMarket Capitalization$29.58 millionAssets Under Management$30.03 millionDividend Yield22.27%Net Expense Ratio0.87%Aggregate RatingN/A ETF Overview Read More Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 ExpensesTypeIDIVNYSEARCA ETFsAll ETFsManagement Fee0.87%0.51%0.53%Other Expenses0.00%0.59%0.56%Total Expense0.87%0.74%0.73%Fee Waiver0.00%-0.71%-0.63%Net Expense0.87%0.58%0.60% Receive IDIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 and its competitors with MarketBeat's FREE daily newsletter. Email Address IDIV ETF News HeadlinesHow to Calculate Cumulative Dividends Per ShareNovember 11, 2024 | fool.comSPDR Series Trust SPDR Homebuilders ETF (ARCA:XHB), DividendsOctober 6, 2024 | benzinga.comPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.July 19 at 2:00 AM | Paradigm Press (Ad)BlackRock Equity Dividend Inv COctober 2, 2024 | morningstar.comMCapital Group US EquitySeptember 5, 2024 | morningstar.comMGMO US Equity IIIAugust 28, 2024 | morningstar.comMSee More Headlines IDIV ETF - Frequently Asked Questions How have IDIV shares performed this year? Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027's stock was trading at $6.96 at the start of the year. Since then, IDIV shares have increased by 0.0% and is now trading at $6.96. How do I buy shares of Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027? Shares of IDIV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 own? Based on aggregate information from My MarketBeat watchlists, some other companies that Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 investors own include Cornerstone Total Return Fund (CRF), Annaly Capital Management (NLY), Cornerstone Strategic Investment Fund (CLM), Verizon Communications (VZ), Arbor Realty Trust (ABR), AbbVie (ABBV) and Magellan Midstream Partners (MMP). Fund Details Issuer Fund NameMetaurus US Equity Cumulative Dividends Fund Series 2027 Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IDIV Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$30.03 million Average Daily Volume$33.57 thousand Discount/Premium-0.09% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares4,250,000BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NYSEARCA:IDIV) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 Please log in to your account or sign up in order to add this asset to your watchlist. Share Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
